Innovations in assisted reproductive technologies: impact on contemporary donor egg practice and future advances

Mindy Sue Christianson, José Bellver

Research output: Contribution to journalReview article

Abstract

Innovations in assisted reproductive technologies (ART) have driven progress in the donor egg field since the birth of the first baby derived from a donor egg in 1983. Over time, donor oocytes have become an increasingly used option for patients unable to conceive with autologous oocytes. In donor egg, the unique separation of the oocyte source and recipient uterus has created a model that has propelled advances in ART. Progressive ART innovations that have optimized the oocyte donor and resulting embryo include the following: evaluation of ovarian reserve, controlled ovarian hyperstimulation regimens that reduce the risk of ovarian hyperstimulation syndrome, blastocyst culture, oocyte cryopreservation, and preimplantation genetic testing. For donor egg recipients, methods to optimize the endometrium to maximize implantation include endometrial receptivity testing, immunologic donor-recipient matching, and increased understanding of the uterine microbiome.

Original languageEnglish (US)
Pages (from-to)994-1002
Number of pages9
JournalFertility and Sterility
Volume110
Issue number6
DOIs
StatePublished - Nov 1 2018

Fingerprint

Assisted Reproductive Techniques
Ovum
Tissue Donors
Oocytes
Ovarian Hyperstimulation Syndrome
Birth Order
Microbiota
Cryopreservation
Genetic Testing
Blastocyst
Endometrium
Uterus
Embryonic Structures

Keywords

  • assisted reproductive technology
  • donor egg
  • Oocyte donation

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Innovations in assisted reproductive technologies : impact on contemporary donor egg practice and future advances. / Christianson, Mindy Sue; Bellver, José.

In: Fertility and Sterility, Vol. 110, No. 6, 01.11.2018, p. 994-1002.

Research output: Contribution to journalReview article

@article{0c6fb2ad97cb44c4898e512d001835fe,
title = "Innovations in assisted reproductive technologies: impact on contemporary donor egg practice and future advances",
abstract = "Innovations in assisted reproductive technologies (ART) have driven progress in the donor egg field since the birth of the first baby derived from a donor egg in 1983. Over time, donor oocytes have become an increasingly used option for patients unable to conceive with autologous oocytes. In donor egg, the unique separation of the oocyte source and recipient uterus has created a model that has propelled advances in ART. Progressive ART innovations that have optimized the oocyte donor and resulting embryo include the following: evaluation of ovarian reserve, controlled ovarian hyperstimulation regimens that reduce the risk of ovarian hyperstimulation syndrome, blastocyst culture, oocyte cryopreservation, and preimplantation genetic testing. For donor egg recipients, methods to optimize the endometrium to maximize implantation include endometrial receptivity testing, immunologic donor-recipient matching, and increased understanding of the uterine microbiome.",
keywords = "assisted reproductive technology, donor egg, Oocyte donation",
author = "Christianson, {Mindy Sue} and Jos{\'e} Bellver",
year = "2018",
month = "11",
day = "1",
doi = "10.1016/j.fertnstert.2018.09.020",
language = "English (US)",
volume = "110",
pages = "994--1002",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Innovations in assisted reproductive technologies

T2 - impact on contemporary donor egg practice and future advances

AU - Christianson, Mindy Sue

AU - Bellver, José

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Innovations in assisted reproductive technologies (ART) have driven progress in the donor egg field since the birth of the first baby derived from a donor egg in 1983. Over time, donor oocytes have become an increasingly used option for patients unable to conceive with autologous oocytes. In donor egg, the unique separation of the oocyte source and recipient uterus has created a model that has propelled advances in ART. Progressive ART innovations that have optimized the oocyte donor and resulting embryo include the following: evaluation of ovarian reserve, controlled ovarian hyperstimulation regimens that reduce the risk of ovarian hyperstimulation syndrome, blastocyst culture, oocyte cryopreservation, and preimplantation genetic testing. For donor egg recipients, methods to optimize the endometrium to maximize implantation include endometrial receptivity testing, immunologic donor-recipient matching, and increased understanding of the uterine microbiome.

AB - Innovations in assisted reproductive technologies (ART) have driven progress in the donor egg field since the birth of the first baby derived from a donor egg in 1983. Over time, donor oocytes have become an increasingly used option for patients unable to conceive with autologous oocytes. In donor egg, the unique separation of the oocyte source and recipient uterus has created a model that has propelled advances in ART. Progressive ART innovations that have optimized the oocyte donor and resulting embryo include the following: evaluation of ovarian reserve, controlled ovarian hyperstimulation regimens that reduce the risk of ovarian hyperstimulation syndrome, blastocyst culture, oocyte cryopreservation, and preimplantation genetic testing. For donor egg recipients, methods to optimize the endometrium to maximize implantation include endometrial receptivity testing, immunologic donor-recipient matching, and increased understanding of the uterine microbiome.

KW - assisted reproductive technology

KW - donor egg

KW - Oocyte donation

UR - http://www.scopus.com/inward/record.url?scp=85055860756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055860756&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2018.09.020

DO - 10.1016/j.fertnstert.2018.09.020

M3 - Review article

C2 - 30396567

AN - SCOPUS:85055860756

VL - 110

SP - 994

EP - 1002

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 6

ER -